Vimarsana
Biggest News Aggregation in the World

Page 2 - Written Description News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Written Description. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Written Description Today - Breaking & Trending Today

Amicus Briefing in Amgen v. Sanofi: The Rest of the Story | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Amicus Briefing in Amgen v. Sanofi: The Rest of the Story | McDonnell Boehnen Hulbert & Berghoff LLP

The Supreme Court's consideration of the standards for satisfying the enablement provisions of 35 U.S.C. 112(a) has been occasioned for the first time in over a century by the Court's...

No Source Code == No Patent - Vimarsana News

No Source Code == No Patent

How we know you "have' the invention

Hold That Generic, Please: Supreme Court Grants Emergency Request To Stay Federal Circuit's Mandate - Patent - Vimarsana News

Hold That Generic, Please: Supreme Court Grants Emergency Request To Stay Federal Circuit's Mandate - Patent

In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis's emergency request for a stay of a mandate from the US Court of Appeals...

Source: mondaq.com
Federal Circuit Trumped By Supreme Court On Stay Of Mandate In Gilenya - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Federal Circuit Trumped By Supreme Court On Stay Of Mandate In Gilenya - Life Sciences, Biotechnology & Nanotechnology

Just two days after the Federal Circuit denied a stay of its mandate in Novartis v. HEC Pharm Co., Ltd., the Supreme Court granted a stay of the mandate pending a further order...

Source: mondaq.com
Written Description Support For Negative Limitation Reconsidered - Vimarsana News

Written Description Support For Negative Limitation Reconsidered

A need for a negative claim limitation often does not arise until the application is undergoing prosecution. For example, an unexpected prior art publication may be cited that requires an element the invention does not.